155 related articles for article (PubMed ID: 12730015)
21. Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour.
Guvenc T; Haligur M; Orman MN; Haziroglu R
Acta Vet Hung; 2002; 50(3):315-21. PubMed ID: 12237973
[TBL] [Abstract][Full Text] [Related]
22. Proliferation characteristics of canine transmissible venereal tumor.
Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
[TBL] [Abstract][Full Text] [Related]
23. Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase.
Mukaratirwa S; Chiwome T; Chitanga S; Bhebhe E
Vet Res Commun; 2006 Aug; 30(6):613-21. PubMed ID: 16838203
[TBL] [Abstract][Full Text] [Related]
24. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
25. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
26. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
[TBL] [Abstract][Full Text] [Related]
27. Immunology of naturally transmissible tumours.
Siddle HV; Kaufman J
Immunology; 2015 Jan; 144(1):11-20. PubMed ID: 25187312
[TBL] [Abstract][Full Text] [Related]
28. Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype.
Ojeda J; Mieres M; Soto F; Arnes V; Paredes E; Navarrete M
J Vet Intern Med; 2018 May; 32(3):1172-1177. PubMed ID: 29604101
[TBL] [Abstract][Full Text] [Related]
29. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
Bautista-Gómez L; Martínez-Castañeda S
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
[TBL] [Abstract][Full Text] [Related]
30. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis.
Setthawongsin C; Techangamsuwan S; Tangkawattana S; Rungsipipat A
J Vet Med Sci; 2016 Aug; 78(7):1167-73. PubMed ID: 27075116
[TBL] [Abstract][Full Text] [Related]
31. Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors.
Akkoc A; Nak D; Demirer A; Şimşek G
Biotech Histochem; 2017; 92(2):100-106. PubMed ID: 28296543
[TBL] [Abstract][Full Text] [Related]
32. Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth.
Mukaratirwa S; Chimonyo M; Obwolo M; Gruys E; Nederbragt H
Histol Histopathol; 2004 Oct; 19(4):1117-23. PubMed ID: 15375754
[TBL] [Abstract][Full Text] [Related]
33. Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element.
Liao KW; Lin ZY; Pao HN; Kam SY; Wang FI; Chu RM
J Vet Diagn Invest; 2003 Sep; 15(5):399-406. PubMed ID: 14535538
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
35. Heat shock proteins in canine transmissible venereal tumor.
Chu RM; Sun TJ; Yang HY; Wang DG; Liao KW; Chuang TF; Lin CH; Lee WC
Vet Immunol Immunopathol; 2001 Sep; 82(1-2):9-21. PubMed ID: 11557291
[TBL] [Abstract][Full Text] [Related]
36. Canine transmissible venereal tumor - From general to molecular characteristics: A review.
Faro TAS; de Oliveira EHC
Anim Genet; 2023 Feb; 54(1):82-89. PubMed ID: 36259378
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.
Chiang HC; Wang YS; Chou CH; Liao AT; Chu RM; Lin CS
BMC Vet Res; 2012 Nov; 8():216. PubMed ID: 23136963
[TBL] [Abstract][Full Text] [Related]
39. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study of canine transmissible venereal tumour in Grenada, West Indies.
Schectman SJ; Khanam A; Walters MND; Kirwan E; Sylvester WR; Khan FA
Vet Med Sci; 2022 May; 8(3):1008-1012. PubMed ID: 35238497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
